Literature DB >> 17226899

Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests?

Francesco Costa1, Maria Gloria Mumolo, Santino Marchi, Massimo Bellini.   

Abstract

Abdominal pain and bowel habits alterations are common symptoms in the general population. The investigation to differentiate organic from functional bowel disorders represents a considerable burden both for patients and public health service. The selection of patients who should undergo endoscopic and/or radiological procedures is one of the key points of the diagnostic process, which should avoid the abuse of invasive and expensive tests as well as the underestimation of potentially harmful diseases. Over the coming years, clinicians and researchers will be challenged to develop strategies to increase the patient's compliance and to reduce the economic and social costs of the intestinal diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17226899      PMCID: PMC4065948          DOI: 10.3748/wjg.v13.i2.219

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  58 in total

1.  Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.

Authors:  S Dolwani; M Metzner; J J Wassell; A Yong; A B Hawthorne
Journal:  Aliment Pharmacol Ther       Date:  2004-09-15       Impact factor: 8.171

2.  Production and excretion of hydrogen gas in man.

Authors:  M D Levitt
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

3.  Small bowel bacterial overgrowth is a common cause of chronic diarrhea.

Authors:  Marcus Teo; Stephen Chung; Lauri Chitti; Cuong Tran; Stamatiki Kritas; Ross Butler; Adrian Cummins
Journal:  J Gastroenterol Hepatol       Date:  2004-08       Impact factor: 4.029

4.  Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.

Authors:  D Franchimont; S Vermeire; H El Housni; M Pierik; K Van Steen; T Gustot; E Quertinmont; M Abramowicz; A Van Gossum; J Devière; P Rutgeerts
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

5.  Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study.

Authors:  P G Farup; K W Monsbakken; P O Vandvik
Journal:  Scand J Gastroenterol       Date:  2004-07       Impact factor: 2.423

6.  Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen.

Authors:  I Dale; M K Fagerhol; I Naesgaard
Journal:  Eur J Biochem       Date:  1983-07-15

7.  Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis.

Authors:  Brennan M R Spiegel; Vincent P DeRosa; Ian M Gralnek; Victor Wang; Gareth S Dulai
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

8.  Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria.

Authors:  P O Vandvik; L Aabakken; P G Farup
Journal:  Scand J Gastroenterol       Date:  2004-05       Impact factor: 2.423

9.  Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum.

Authors:  G R Vantrappen; P J Rutgeerts; Y F Ghoos; M I Hiele
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

10.  Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial.

Authors:  W Atkinson; T A Sheldon; N Shaath; P J Whorwell
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

View more
  2 in total

Review 1.  Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy.

Authors:  Massimo Bellini; Dario Gambaccini; Cristina Stasi; Maria Teresa Urbano; Santino Marchi; Paolo Usai-Satta
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 2.  Carbohydrate malabsorption in patients with non-specific abdominal complaints.

Authors:  Peter Born
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.